about
Hospital Mortality in the United States following Acute Kidney InjuryChoice of Reference Serum Creatinine in Defining Acute Kidney InjuryiDASH: integrating data for analysis, anonymization, and sharingEvaluating the discriminatory power of a computer-based system for assessing penetrating trauma on retrospective multi-center data.A comparison of methods for assessing penetrating trauma on retrospective multi-center dataValidation of an automated safety surveillance system with prospective, randomized trial dataAdverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention.Quantitative impact of cardiovascular risk factors and vascular closure devices on the femoral artery after repeat cardiac catheterizationAnalyses of longitudinal, hospital clinical laboratory data with application to blood glucose concentrations.Laboratory test surveillance following acute kidney injuryCommonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury.Evaluation of an automated safety surveillance system using risk adjusted sequential probability ratio testing.Quantifying the learning curve in the use of a novel vascular closure device: an analysis of the NCDR (National Cardiovascular Data Registry) CathPCI registry.Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary interventionMonitoring device safety in interventional cardiology.An evaluation of a distributed medical device safety surveillance system: the DELTA network studyExploration of a Bayesian updating tool to provide real-time safety monitoring for new medical devices.Timeliness of interfacility transfer for ED patients with ST-elevation myocardial infarction.Outpatient nephrology referral rates after acute kidney injuryA cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention.Estimating baseline kidney function in hospitalized patients with impaired kidney functionVascular closure device failure in contemporary practice.Effects of SVM parameter optimization on discrimination and calibration for post-procedural PCI mortality.Use of multiple imputation method to improve estimation of missing baseline serum creatinine in acute kidney injury research.Prognosis in critical care.Treatment intensification and blood glucose control among hospitalized diabetic patientsA randomized trial of electronic clinical reminders to improve medication laboratory monitoring.Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records.Development of inpatient risk stratification models of acute kidney injury for use in electronic health records.Exploring the frontier of electronic health record surveillance: the case of postoperative complications.Risk-treatment paradox in the selection of transradial access for percutaneous coronary interventionAdverse drug events during AKI and its recoveryReduced Mortality Associated with Acute Kidney Injury Requiring Dialysis in the United States.Impact of non-interruptive medication laboratory monitoring alerts in ambulatory care.Risk-adjusted sequential probability ratio test control chart methods for monitoring operator and institutional mortality rates in interventional cardiology.Incidence and In-Hospital Mortality of Acute Kidney Injury (AKI) and Dialysis-Requiring AKI (AKI-D) After Cardiac Catheterization in the National Inpatient Sample.Rare adverse event monitoring of medical devices with the use of an automated surveillance toolHypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward.Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices.Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney.
P50
Q26744765-087DFE2B-9765-40A7-9492-4703B44EAF1AQ26786536-306FC388-732C-44B2-8456-FE177215FCB7Q28732138-38BB7CF6-728D-49D9-BAA3-41BC144D7CC2Q31044466-B1BF73D6-0491-45E8-85C4-72880841FC68Q33377711-6DA3F279-1A37-4119-96D3-FF46C59814A4Q33385061-B86438C7-F480-4EA5-B863-90D17AC46416Q33611340-5E35B01D-CB8C-4CD0-9A9F-A0DA0462D117Q33640467-A61482D1-8910-4C81-B61C-891C44B758E5Q34030816-B8075B80-728A-441F-ADCE-FB3CC2765139Q34035017-D503D942-7FE5-4A7A-97B3-5A1851B9023CQ34090056-598D8FF4-95FC-423F-918B-8252D4E83FCBQ34101009-4C37B5FC-FD1D-451D-8DF0-7310C77FE5E1Q34121986-BF12BA94-F6C5-42BE-B899-D51D7672DA1BQ34254766-50F80987-103F-4B54-A27D-D638BA383C45Q34565273-6ED5F07F-A3CE-4EBB-95F5-B75BCCB986A2Q34756859-C7DF9CB9-F326-4223-A89E-57B14BCF64BAQ35018364-83FD765F-9FB3-4828-BE3B-43AFC61426F7Q35269703-77F77AFA-D287-480E-A18C-318BF296E258Q35715776-62DA8B5C-CFFE-450A-9DB8-B4B239704593Q35781620-0F7C1D9A-161C-4BDE-B114-0FD8D71407E8Q35917438-81DA1342-245E-4F83-B48B-77C07BAC7769Q36188849-376086E9-C61B-48AE-A5DA-4088CCA06CEDQ36319325-6DFB30BC-D534-4ABB-8F49-71D552D6D0E7Q36492516-D1D133F1-FBE4-4795-90E1-78CC8A87A036Q36533392-B5488F05-111D-4F75-BD48-FA53A9D1C017Q36607245-E6255DA6-F935-419E-85AB-FEEB61CE07A4Q36741423-E666ECC6-99FA-46C0-BE7A-9815C95A9B16Q36771146-9570FC62-D458-4869-B3BB-AAEC65B77A95Q36850739-86A613C1-3041-4EF7-82BA-2442C3B0EECAQ36856290-C0657F75-2DBA-4B66-96AE-3E8B1BD790A4Q36974310-E2286285-C050-48F0-AF08-66A4516CD5B1Q36980380-F32A5114-CE77-4B6C-AAC6-3C2226224B0DQ36984517-9AD723FB-CAF4-4372-BA51-0598EBE1B395Q37020614-3828A8A4-4C24-41C6-9C79-ECB36EA91CB3Q37033057-9B3F3928-CD98-44B0-8E45-DF6CEF95A968Q37090745-5DFEA477-DAD8-44DE-BEEB-EAC0E874A25EQ37128473-1BC035D1-81D2-420D-B9EE-47555F189F55Q37235921-0FF04291-1D89-4FD9-BEA9-75E8DCDBD3E8Q37458616-18276409-4A7B-4F62-BC32-5AF0C9B98A5FQ37598530-4165A90A-BC54-4A49-8692-E682B46A9F83
P50
description
bioinformatician
@en
hulumtues
@sq
wetenschapper
@nl
հետազոտող
@hy
name
Michael E Matheny
@ast
Michael E Matheny
@es
Michael E Matheny
@nl
Michael E Matheny
@sl
Michael E. Matheny
@en
type
label
Michael E Matheny
@ast
Michael E Matheny
@es
Michael E Matheny
@nl
Michael E Matheny
@sl
Michael E. Matheny
@en
prefLabel
Michael E Matheny
@ast
Michael E Matheny
@es
Michael E Matheny
@nl
Michael E Matheny
@sl
Michael E. Matheny
@en
P106
P21
P2456
P31
P496
0000-0003-3217-4147
P569
2000-01-01T00:00:00Z